2267. Pre-Operative Embolization in Carotid Body Tumors: A Single Centre Experience in India
Authors* Denotes Presenting Author
Sunanda Nimmalapudi *;
Pinnamaneni Siddhartha Institute of Medical Sciences
The purpose of this study is to compare the efficiency of preoperative embolization on vascular rupture rates during surgery in 260 patients within two groups.
Materials and Methods:
Prospective medical records of 140 patients who did undergo preoperative tumor embolization and 120 patients who did not undergo embolization were reviewed. All patients underwent surgical resection of a carotid body tumor from January 2014 to April 2020 within a tertiary care hospital. Demographic data including age, gender, and tumor size were collected. Glomic artery supply was evaluated with digital subtraction angiography in each patient. The degree of flow reduction was calculated instantly following each injection of embolic material. Complications of embolization were also collected. The estimated blood loss and the operation time were obtained from intraoperative records and operative notes dictated at the time of surgery. Operative records were evaluated for carotid artery rupture and Shamblin classification of glomus tumors.
The mean patient age was 48.5 years (range 22–70), and 60 patients were male, 200 were female. All of the patients except 20 patients had Shamblin classification II. The mean diameter of tumor size was 4.42 cm. Relative rates of blood flow reduction during embolization were greater than 80% in 80 patients and 75% in 60 patients. Carotid artery injury was recorded in 10 patients within embolization group and in 20 patients within the other group. There was significant differences between carotid artery rupture and embolization, blood loss, tumor size, and supplying artery.
Transarterial preoperative embolization of carotid body tumors reduces the estimated blood loss during surgery leading to better delineation of the tumor margins, improving the ease of resection, reducing the operating time and the number blood transfusions without any significant complications.